| تعداد نشریات | 282 |
| تعداد نشریات سازمان | 80 |
| تعداد شماره‌ها | 3,273 |
| تعداد مقالات | 36,170 |
| تعداد مشاهده مقاله | 55,727,909 |
| تعداد دریافت فایل اصل مقاله | 94,506,999 |
Expression and Purification of LigA Antigen, a Surface Lipoprotein in the Pathogenic Leptospira interrogans | ||
| Archives of Razi Institute | ||
| مقاله 12، دوره 81، شماره 1، فروردین و اردیبهشت 2026، صفحه 99-110 اصل مقاله (3.09 M) | ||
| نوع مقاله: Original Articles | ||
| شناسه دیجیتال (DOI): 10.66224/ARI.81.1.3450 | ||
| نویسندگان | ||
| Aida Chalesh1؛ Pejvak Khaki* 2؛ Sohaila Moradi Bidhendi2؛ Majid Tebianian3؛ Morteza Taghizadeh Tarnabi4 | ||
| 1Department of Microbiology, NT.C., Islamic Azad University, Tehran, Iran. | ||
| 2Department of Microbiology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. | ||
| 3Department of Immunology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. | ||
| 4Department of Medical Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. | ||
| چکیده | ||
| Introduction: Although considerable progress has been made in leptospiral vaccine development, their use is limited because of short-term and serovar-specific immunity. Thus far, many approaches have been used to identify heterologous and costeffective antigen(s) against leptospirosis. Recent advances have identified leptospiral immunoglobulin-like (Lig) proteins as promising candidates for vaccine development. Materials & Methods: Hence, in this study, the recombinant LigA subunit consists of the ligA9, ligA10, ligA11, and ligA12 domains, were selected as conserved regions of the LigA protein. Immunoinformatics approaches, including I-TASSER, ProSA, DiscoTope v2.0, and Molprobity were utilized to check the conformational accuracy. Furthermore, 10 of the most efficient peptides for MHC-I and II grooves were predicted by the ElliPro, NetMHCpan 4.1 EL and NetMHCIIpan 4.1 EL servers. Results: The Ramachandran plot showed acceptable conformations of the selected recombinant protein amino acid residues. The results showed that selected epitopes elicit both humoral- and cell-mediated immune responses. Hence, the selected epitopes were constructed in the pET41a+ plasmid and synthesized by General Biosystems. Recombinant plasmids were transferred to Escherichia coli Top10-DH5α and BL21 StarTM (DE3) competent cells for cloning and expression, respectively. Plasmid transformation and purification were confirmed using polymerase chain reaction (PCR) and enzymatic digestion. Recombinant LigA (r-LigA) was expressed in the presence of 0.5 M IPTG at 30˚C for 16 hours. The sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE) result revealed the production of 38-kDa protein, which accumulated mostly in inclusion bodies and was purified using the urea method and dialysis. Dot blotting of the r-LigA protein confirmed a high degree of accuracy of immunogenicity. Conclusion: The present study revealed that r-LigA is a promising candidate for developing diagnostic and subunit leptospirosis vaccines. | ||
| کلیدواژه‌ها | ||
| Leptospirosis؛ Immunoinformatics approaches؛ Recombinant protein؛ LigA epitope | ||
| عنوان مقاله [English] | ||
| بیان و خالص سازی آنتی ژن LigA، یک لیپوپروتئین سطحی در سرووار بیماری زا Leptospira | ||
|
سایر فایل های مرتبط با مقاله
|
||
| مراجع | ||
|
Breda LC, Hsieh CL, Castiblanco Valencia MM, da Silva LB, Barbosa AS, Blom AM, et al. Fine mapping of the interaction between C4b-binding protein and outer membrane proteins LigA and LigB of pathogenic Leptospira interrogans. PLoS Negl Trop Dis. 2015; 9(10):e0004192. [DOI:10.1371/journal.pntd.0004192] [PMID]
Bashiru G, Bahaman AR. Advances & challenges in leptospiral vaccine development. Indian J Med Res. 2018; 147(1):15-22. [DOI:10.4103/ijmr.IJMR_1022_16][PMID]
Dellagostin OA, Grassmann AA, Hartwig DD, Félix SR, da Silva EF, McBride AJ. Recombinant vaccines against leptospirosis. Hum Vaccin. 2011; 7(11):1215-24. [DOI:10.4161/hv.7.11.17944] [PMID]
Koizumi N, Watanabe H. Leptospirosis vaccines: Past, present, and future. J Postgrad Med. 2005; 51(3):210-4. [PMID]
Haake DA, Zückert WR. The leptospiral outer membrane. Curr Top Microbiol Immunol. 2015; 387:187-221. [DOI:10.1007/978-3-662-45059-8_8][PMID]
Barazzone GC, Teixeira AF, Azevedo BOP, Damiano DK, Oliveira MP, Nascimento ALTO,et al. Revisiting the development of vaccines against pathogenic Leptospira: Innovative approaches, present challenges, and future perspectives. Front Immunol. 2022; 12:760291. [DOI:10.3389/fimmu.2021.760291][PMID]
Haake DA, Matsunaga J. Leptospiral Immunoglobulin-like domain proteins: Roles in virulence and immunity. Front Immunol. 2021; 11:579907. [DOI:10.3389/fimmu.2020.579907][PMID]
Croda J, Ramos JG, Matsunaga J, Queiroz A, Homma A, Riley LW, et al. Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis. J Clin Microbiol. 2007; 45(5):1528-34. [DOI:10.1128/JCM.02344-06][PMID]
Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008; 9:40. [DOI:10.1186/1471-2105-9-40] [PMID]
Matsunaga J, Barocchi MA, Croda J, Young TA, Sanchez Y, Siqueira I, et al. Pathogenic Leptospira species express surface‐exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol. 2003; 49(4):929-45. [DOI:10.1046/j.1365-2958.2003.03619.x][PMID]
Behera SK, Sabarinath T, Mishra PKK, Deneke Y, Kumar A, ChandraSekar S, et al. Immunoinformatic study of recombinant liga/bcon1-5 antigen and evaluation of its diagnostic potential in primary and secondary binding tests for serodiagnosis of porcine leptospirosis. Pathogens. 2021; 10(9):1082. [DOI:10.3390/pathogens10091082] [PMID]
Wiederstein M, Sippl MJ. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007; 35(suppl_2):W407-10. [DOI:10.1093/nar/gkm290]
Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2018; 27(1):293-315. [DOI:10.1002/pro.3330]
Høie MH, Gade FS, Johansen JM, Würtzen C, Winther O, Nielsen M, Marcatili P. DiscoTope-3.0: improved B-cell epitope prediction using inverse folding latent representations. Front Immunol. 2024; 15:1322712. [DOI:10.3389/fimmu.2024.1322712]
Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, Greenbaum J, et al. Immune epitope database analysis resource. Nucleic Acids Res. 2012; 40(W1):W525-30. [DOI: 10.1093/nar/gkn254]
Andreatta M, Nielsen M. Gapped sequence alignment using artificial neural networks: Application to the MHC class I system. 2016; 32(4):511-7. [DOI:10.1093/bioinformatics/btv639][PMID]
BioFact Co. BioFact™ Plasmid Mini Prep Kit. BioFact Co., Ltd (South Korea). 2026 [Updted 7April 2026]. Available from: [Link]
Golab N, Khaki P, Harzandi N, Esmaelizad M, Tebianian M. Expression and purification of the Lipl41, a surface-exposed lipoprotein antigen of pathogenic Leptospira spp. Vet Arch. 2020; 90(3):297-305. [Link]
Srivastava SK. Prospects of developing leptospiral vaccines for animals. Indian J Med Microbiol. 2006; 24(4):331-6. [DOI:10.4103/0255-0857.29412] [PMID]
Techawiwattanaboon T, Patarakul K. Update on molecular diagnosis of human leptospirosis. Asian Biomed. 2019; 13(6):207-16. [DOI:10.1515/abm-2019-0063]
Varma VP, Kadivella M, Kavela S, Faisal SM. Leptospira lipid A Is a potent adjuvant that induces sterilizing immunity against leptospirosis. Vaccines (Basel). 2023; 11(12):1824. [DOI:10.3390/vaccines11121824][PMID]
Koizumi N, Watanabe H. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine. 2004; 22 (11-12):1545-52. [DOI:10.1016/j.vaccine.2003.10.007] [PMID]
Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine. 2007; 25(33):6277-86. [DOI:10.1016/j.vaccine.2007.05.053][PMID]
McBride AJ, Cerqueira GM, Suchard MA, Moreira AN, Zuerner RL, Reis MG, et al. Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol. 2009; 9(2):196-205. [DOI:10.1016/j.meegid.2008.10.012][PMID]
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: Protein structure and function prediction. Nat Methods. 2015; 12(1):7-8. [DOI:10.1038/nmeth.3213][PMID]
Lin Xa, Sun A, Ruan P, Zhang Z, Yan J. Characterization of conserved combined T and B cell epitopes in Leptospira interrogans major outer membrane proteins OmpL1 and LipL41. BMC Microbiol. 2011; 11(1):21. [DOI:10.1186/1471-2180-11-21][PMID]
Fookolaee SP, Talebishelimaki S, Rad MT, Rokni MA. In silico prediction of B cell epitopes of the hemolysis-associated protein 1 for vaccine design against leptospirosis. J Curr Biomed Rep. 2020; 1(1):32-7. [Link]
Kapoor K, Patel A, Shekh S, Joshi CG. Designing of multiepitope subunit vaccine against leptospirosis using immunoinformatics approach. 2022. Preprints. [DOI:10.20944/preprints202212.0299.v1]
Hartwig DD, Oliveira TL, Seixas FK, Forster KM, Rizzi C, Hartleben CP, et al. High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris. Microb Cell Fact. 2010; 9:98.[DOI:10.1186/1475-2859-9-98][PMID]
Matsunaga J, Sanchez Y, Xu X, Haake DA. Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun. 2005; 73(1):70-8. [DOI:10.1128/IAI.73.1.70-78.2005][PMID]
Palaniappan RU, Chang YF, Jusuf SS, Artiushin S, Timoney JF, McDonough SP, et al. Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun. 2002; 70(11):5924-30. [DOI:10.1128/IAI.70.11.5924-5930.2002][PMID]
Figueira CP, Croda J, Choy HA, Haake DA, Reis MG, Ko AI, et al. Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin. BMC Microbiol. 2011; 11:129. [DOI:10.1186/1471-2180-11-129][PMID]
Bhatwa A, Wang W, Hassan YI, Abraham N, Li XZ, Zhou T. Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications. Front Bioeng Biotechnol. 2021; 9:630551. [DOI:10.3389/fbioe.2021.630551] [PMID] | ||
|
آمار تعداد مشاهده مقاله: 829 تعداد دریافت فایل اصل مقاله: 704 |
||
